Johnson & Johnson (NYSE: JNJ) is an elite dividend stock. The healthcare giant has increased its dividend payment for 62 years in a row. The iconic healthcare company backs its high-yielding payout with a very healthy financial profile.

The same is true for stocks. Consider that global icon Apple Inc. (ticker: AAPL) yields a mere 0.4%, despite having roughly $100 billion in net income and one of the most entrenched brands in the planet. That's because it's easy to maintain a nominal dividend, but much harder to drive a huge yield – even for titans like Apple.

British American Tobacco (NYSE: BTI), commonly known as BAT, exemplifies this dynamic. Over the prior 10 years, BAT shares have significantly underperformed both the broader market and many of its tobacco industry peers.

Many dividend stocks lost their luster in 2022 and 2023 as rising interest rates drove jittery investors toward safer CDs, Treasury bills, and other fixed-income investments. However, many of those high-yielding dividend stocks stabilized in 2024 as the Federal Reserve finally implemented three interest rate cuts.

What would it take to make over $3,000 this year with only barely lifting a finger? My answer is having $50,000 and spending five minutes or so using an online brokerage. Could it really be that easy?

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other

A quarterly dividend payment from a high-quality stock may be as close to a sure thing as an investor can find on Wall Street. Even during periods of broad market weakness, the lower a stock's price falls,

These five smaller-cap companies pay ultra-high-yield dividends and could offer patient investors enormous returns for 2025 and beyond.